1
|
Roquini V, Mengarda AC, Cajas RA, Martins-da-Silva MF, Godoy-Silva J, Santos GA, Espírito-Santo MCC, Pavani TFA, Melo VA, Salvadori MC, Teixeira FS, Rando DGG, de Moraes J. The Existing Drug Nifuroxazide as an Antischistosomal Agent: In Vitro, In Vivo, and In Silico Studies of Macromolecular Targets. Microbiol Spectr 2023; 11:e0139323. [PMID: 37409934 PMCID: PMC10434008 DOI: 10.1128/spectrum.01393-23] [Citation(s) in RCA: 4] [Impact Index Per Article: 4.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/30/2023] [Accepted: 06/15/2023] [Indexed: 07/07/2023] Open
Abstract
Schistosomiasis is a parasitic disease that afflicts approximately 250 million people worldwide. There is an urgent demand for new antiparasitic agents because praziquantel, the only drug available for the treatment of schistosomiasis, is not universally effective and may derail current progress toward the WHO goal of eliminating this disease as a public health problem by 2030. Nifuroxazide (NFZ), an oral nitrofuran antibiotic, has recently been explored to be repurposed for parasitic diseases. Here, in vitro, in vivo, and in silico studies were conducted to evaluate the activity of NFZ on Schistosoma mansoni. The in vitro study showed significant antiparasitic activity, with 50% effective concentration (EC50) and 90% effective concentration (EC90) values of 8.2 to 10.8 and 13.7 to 19.3 μM, respectively. NFZ also affected worm pairing and egg production and induced severe damage to the tegument of schistosomes. In vivo, a single oral dose of NFZ (400 mg/kg of body weight) to mice harboring either prepatent or patent S. mansoni infection significantly reduced the total worm burden (~40%). In patent infection, NFZ achieved a high reduction in the number of eggs (~80%), but the drug caused a low reduction in the egg burden of animals with prepatent infection. Finally, results from in silico target fishing methods predicted that serine/threonine kinases could be one of the potential targets for NFZ in S. mansoni. Overall, the present study revealed that NFZ possesses antischistosomal properties, mainly in terms of egg burden reduction in animals with patent S. mansoni infection. IMPORTANCE The increasing recognition of the burden imposed by helminthiasis, associated with the limited therapeutic arsenal, has led to initiatives and strategies to research and develop new drugs for the treatment of schistosomiasis. One of these strategies is drug repurposing, which considers low-risk compounds with potentially reduced costs and shorter time for development. In this study, nifuroxazide (NFZ) was evaluated for its anti-Schistosoma mansoni potential through in vitro, in vivo, and in silico studies. In vitro, NFZ affected worm pairing and egg production and induced severe damage to the tegument of schistosomes. In vivo, a single oral dose of NFZ (400 mg/kg) to mice harboring either prepatent or patent S. mansoni infection significantly reduced the total worm burden and egg production. In silico investigations have identified serine/threonine kinases as a molecular target for NFZ. Collectively, these results implied that NFZ might be a potential therapeutic candidate for the treatment of schistosomiasis.
Collapse
Affiliation(s)
- Vinícius Roquini
- Research Center on Neglected Diseases, Guarulhos University, Guarulhos, São Paulo, Brazil
| | - Ana C. Mengarda
- Research Center on Neglected Diseases, Guarulhos University, Guarulhos, São Paulo, Brazil
| | - Rayssa A. Cajas
- Research Center on Neglected Diseases, Guarulhos University, Guarulhos, São Paulo, Brazil
| | | | - Julia Godoy-Silva
- Research Center on Neglected Diseases, Guarulhos University, Guarulhos, São Paulo, Brazil
| | - Gustavo A. Santos
- Research Center on Neglected Diseases, Guarulhos University, Guarulhos, São Paulo, Brazil
| | - Maria Cristina C. Espírito-Santo
- Laboratory of Immunopathology of Schistosomiasis (LIM-06), Department of Infectious and Parasitic Diseases, Faculty of Medicine, University of São Paulo, São Paulo, São Paulo, Brazil
- Laboratory of Helminthology, Institute of Tropical Medicine, University of São Paulo, São Paulo, São Paulo, Brazil
| | - Thais F. A. Pavani
- Biological Chemistry Post-Graduate Course, Institute of Environmental, Chemical and Pharmaceutical Sciences, Federal University of São Paulo, Diadema, São Paulo, Brazil
| | - Vanusa A. Melo
- Biological Chemistry Post-Graduate Course, Institute of Environmental, Chemical and Pharmaceutical Sciences, Federal University of São Paulo, Diadema, São Paulo, Brazil
| | - Maria C. Salvadori
- Institute of Physics, University of São Paulo, São Paulo, São Paulo, Brazil
| | | | - Daniela G. G. Rando
- Chemico-Pharmaceutical Research Group, Institute of Environmental, Chemical and Pharmaceutical Sciences, Federal University of São Paulo, Diadema, São Paulo, Brazil
| | - Josué de Moraes
- Research Center on Neglected Diseases, Guarulhos University, Guarulhos, São Paulo, Brazil
| |
Collapse
|
2
|
de Souza RL, Mengarda AC, Roquini DB, Melo CO, de Morais MC, C Espírito-Santo MC, de Sousa DP, Moraes JD, Oliveira EE. Enhancing the antischistosomal activity of carvacryl acetate using nanoemulsion. Nanomedicine (Lond) 2023; 18:331-342. [PMID: 37140262 DOI: 10.2217/nnm-2022-0228] [Citation(s) in RCA: 3] [Impact Index Per Article: 3.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 05/05/2023] Open
Abstract
Aim: To formulate a carvacryl acetate nanoemulsion (CANE) and test its antischistosomal activity. Materials & methods: CANE was prepared and tested in vitro on Schistosoma mansoni adult worms and both human and animal cell lines. Next, CANE was administered orally to mice infected with either a prepatent infection or a patent infection of S. mansoni. Results: CANE was stable during 90 days of analysis. CANE showed in vitro anthelmintic activity, and no cytotoxic effects were observed. In vivo, CANE was more effective than the free compounds in reducing worm burden and egg production. Treatment with CANE was more effective for prepatent infections than praziquantel. Conclusion: CANE improves antiparasitic properties and may be a promising delivery system for schistosomiasis treatment.
Collapse
Affiliation(s)
- Rafael L de Souza
- Laboratory of Synthesis & Drug Delivery, State University of Paraíba, João Pessoa, 58071-160, Brazil
| | - Ana C Mengarda
- Research Center for Neglected Diseases, Guarulhos University, Guarulhos, 07023-070, Brazil
| | - Daniel B Roquini
- Research Center for Neglected Diseases, Guarulhos University, Guarulhos, 07023-070, Brazil
| | - Camila O Melo
- Laboratory of Synthesis & Drug Delivery, State University of Paraíba, João Pessoa, 58071-160, Brazil
| | - Mayara C de Morais
- Department of Pharmaceutical Sciences, Federal University of Paraíba, João Pessoa, 58051-900, Brazil
| | - Maria Cristina C Espírito-Santo
- Laboratory of Immunopathology of Schistosomiasis (LIM-06), Department of Infectious & Parasitic Diseases, Faculty of Medicine, University of São Paulo, São Paulo, 01246903, Brazil
- Laboratory of Helminthology, Institute of Tropical Medicine, University of São Paulo, São Paulo, 05403-000, Brazil
| | - Damião P de Sousa
- Department of Pharmaceutical Sciences, Federal University of Paraíba, João Pessoa, 58051-900, Brazil
| | - Josué de Moraes
- Research Center for Neglected Diseases, Guarulhos University, Guarulhos, 07023-070, Brazil
| | - Elquio E Oliveira
- Laboratory of Synthesis & Drug Delivery, State University of Paraíba, João Pessoa, 58071-160, Brazil
| |
Collapse
|
3
|
Mengarda AC, Silva TC, Silva AS, Roquini DB, Fernandes JPS, de Moraes J. Toward anthelmintic drug candidates for toxocariasis: Challenges and recent developments. Eur J Med Chem 2023; 251:115268. [PMID: 36921525 DOI: 10.1016/j.ejmech.2023.115268] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/18/2022] [Revised: 03/07/2023] [Accepted: 03/07/2023] [Indexed: 03/18/2023]
Abstract
Infections caused by parasitic helminths rank among the most prevalent infections of humans and animals. Toxocariasis, caused by nematodes of the genus Toxocara, is one of the most widespread and economically important zoonotic parasitic infections that humans share with dogs and cats. Despite the completion of the Toxocara canis draft genome project, which has been an important step towards advancing the understanding of this parasite and the search for drug targets, the treatment of toxocariasis has been dependent on a limited set of drugs, necessitating the search for novel anthelmintic agents, specially against Toxocara larvae in tissues. Given that research, development, and innovation are crucial to finding appropriate solutions in the fight against helminthiasis, this paper reviews the progress made in the discovery of anthelmintic drug candidates for toxocariasis. The main compounds reported in the recent years regards on analogues of albendazole, reactive quinone derivatives and natural produts and its analogues. Nanoparticles and formulations were also reviewed. The in vitro and/or in vivo anthelmintic properties of such alternatives are herein discussed as well as the opportunities and challenges for treatment of human toxocariasis. The performed review clarify that the scarcity of validated molecular targets and limited chemical space explored are the main bottlenecks for advancing in the field of anti-Toxocara agents.
Collapse
Affiliation(s)
- Ana C Mengarda
- Research Center on Neglected Diseases, Guarulhos University, Praça Tereza Cristina 229, 07023-070, Guarulhos, SP, Brazil.
| | - Tais C Silva
- Research Center on Neglected Diseases, Guarulhos University, Praça Tereza Cristina 229, 07023-070, Guarulhos, SP, Brazil.
| | - Aline S Silva
- Research Center on Neglected Diseases, Guarulhos University, Praça Tereza Cristina 229, 07023-070, Guarulhos, SP, Brazil.
| | - Daniel B Roquini
- Research Center on Neglected Diseases, Guarulhos University, Praça Tereza Cristina 229, 07023-070, Guarulhos, SP, Brazil.
| | - João Paulo S Fernandes
- Department of Pharmaceutical Sciences, Universidade Federal de São Paulo, campus Diadema, Rua São Nicolau 210, 09913-030, Diadema, SP, Brazil.
| | - Josué de Moraes
- Research Center on Neglected Diseases, Guarulhos University, Praça Tereza Cristina 229, 07023-070, Guarulhos, SP, Brazil.
| |
Collapse
|
4
|
Mengarda AC, Iles B, Longo JPF, de Moraes J. Recent approaches in nanocarrier-based therapies for neglected tropical diseases. Wiley Interdiscip Rev Nanomed Nanobiotechnol 2023; 15:e1852. [PMID: 36161523 DOI: 10.1002/wnan.1852] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Subscribe] [Scholar Register] [Received: 01/28/2022] [Revised: 07/09/2022] [Accepted: 08/30/2022] [Indexed: 11/07/2022]
Abstract
Neglected tropical diseases (NTDs) remain major public health problems in developing countries. Reducing the burden of NTDs requires sustained collaborative drug discovery efforts to achieve the goals of the new NTDs roadmap launched by the World Health Organization. Oral drugs are the most convenient choice and usually the safest and least expensive. However, the oral use of some drugs for NTDs treatment has many drawbacks, including toxicity, adverse reactions, drug resistance, drug low solubility, and bioavailability. Since there is an imperative need for novel and more effective drugs to treat the various NTDs, in recent years, several compound-loaded nanoparticles have been prepared with the objective of evaluating their application as an oral drug delivery system for the treatment of NTDs. This review focuses on the various types of nanoparticle drug delivery systems that have been recently used against the major NTDs caused by parasites such as leishmaniasis, Chagas disease, and schistosomiasis. This article is categorized under: Therapeutic Approaches and Drug Discovery > Nanomedicine for Infectious Disease.
Collapse
Affiliation(s)
- Ana C Mengarda
- Research Center for Neglected Diseases, Guarulhos University, Guarulhos, São Paulo, Brazil
| | - Bruno Iles
- Department of Genetics and Morphology, Institute of Biological Sciences, University of Brasília, Brasília, Distrito Federal, Brazil
| | - João Paulo F Longo
- Department of Genetics and Morphology, Institute of Biological Sciences, University of Brasília, Brasília, Distrito Federal, Brazil
| | - Josué de Moraes
- Research Center for Neglected Diseases, Guarulhos University, Guarulhos, São Paulo, Brazil
| |
Collapse
|
5
|
Abstract
INTRODUCTION Infections caused by parasitic flatworms impose a considerable worldwide health burden. Recently, World Health Organization launched its roadmap for neglected diseases for the period 2021 to 2030 and oral treatment with praziquantel (PZQ) in tablet form is the main drug therapy for combating these diseases, but its use is limited by many drawbacks, including the high therapeutic dose due to the drug's low solubility and bioavailability. Among the strategies to improve PZQ performance, the use of drug nanocarriers has been cited as an interesting approach to overcome these pharmacological issues. AREAS COVERED This review focuses on the various types of nanomaterials (polymeric, lipidic, inorganic nanoparticles, and nanocrystals) which have been recently used to improve PZQ therapy. In addition, recent advances in PZQ nanoformulations, developed to overcome the barriers of the conventional drug are described. EXPERT OPINION Considering the poor rate of discovery in the anthelmintic segment observed in recent decades, the effective management of existing drugs has become essential. The application of new strategies based on nanotechnology can extend the useful life of PZQ in new and more effective formulations. Pharmaceutical nanotechnology can solve the pharmacokinetic challenges characteristic of PZQ and improve its solubility and bioavailability.
Collapse
Affiliation(s)
- Ana C Mengarda
- Research Center for Neglected Diseases, Guarulhos University, Guarulhos, SP, Brazil
| | - Bruno Iles
- Department of Genetics and Morphology, Institute of Biological Sciences, University of Brasília, Brasília, DF, Brazil
| | - João Paulo F Longo
- Department of Genetics and Morphology, Institute of Biological Sciences, University of Brasília, Brasília, DF, Brazil
| | - Josué de Moraes
- Research Center for Neglected Diseases, Guarulhos University, Guarulhos, SP, Brazil
| |
Collapse
|
6
|
Morais CS, Mengarda AC, Miguel FB, Enes KB, Rodrigues VC, Espírito-Santo MCC, Siyadatpanah A, Wilairatana P, Couri MRC, de Moraes J. Pyrazoline derivatives as promising novel antischistosomal agents. Sci Rep 2021; 11:23437. [PMID: 34873205 PMCID: PMC8648852 DOI: 10.1038/s41598-021-02792-0] [Citation(s) in RCA: 5] [Impact Index Per Article: 1.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/27/2021] [Accepted: 11/17/2021] [Indexed: 11/19/2022] Open
Abstract
Praziquantel is the only available drug to treat schistosomiasis, a parasitic disease that currently infects more than 240 million people globally. Due to increasing concerns about resistance and inadequate efficacy there is a need for new therapeutics. In this study, a series of 17 pyrazolines (15–31) and three pyrazoles (32–34) were synthesized and evaluated for their antiparasitic properties against ex vivo adult Schistosoma mansoni worms. Of the 20 compounds tested, six had a 50% effective concentration (EC50) below 30 μM. Our best hit, pyrazoline 22, showed promising activity against adult schistosomes, with an EC50 < 10 µM. Additionally, compound 22 had low cytotoxicity, with selectivity index of 21.6 and 32.2 for monkey and human cell lines, respectively. All active pyrazolines demonstrated a negative effect on schistosome fecundity, with a marked reduction in the number of eggs. Structure–activity relationship analysis showed that the presence of the non-aromatic heterocycle and N-substitution are fundamental to the antischistosomal properties. Pharmacokinetics, drug-likeness and medicinal chemistry friendliness studies were performed, and predicted values demonstrated an excellent drug-likeness profile for pyrazolines as well as an adherence to major pharmaceutical companies’ filters. Collectively, this study demonstrates that pyrazoline derivatives are promising scaffolds in the discovery of novel antischistosomal agents.
Collapse
Affiliation(s)
- Cristiane S Morais
- Research Center for Neglected Diseases, Guarulhos University, Praça Tereza Cristina, 229, Centro, Guarulhos, SP, 07023-070, Brazil
| | - Ana C Mengarda
- Research Center for Neglected Diseases, Guarulhos University, Praça Tereza Cristina, 229, Centro, Guarulhos, SP, 07023-070, Brazil
| | - Fábio B Miguel
- Department of Chemistry, Federal University of Juiz de Fora, Juiz de Fora, MG, 36036-900, Brazil
| | - Karine B Enes
- Department of Chemistry, Federal University of Juiz de Fora, Juiz de Fora, MG, 36036-900, Brazil
| | - Vinícius C Rodrigues
- Research Center for Neglected Diseases, Guarulhos University, Praça Tereza Cristina, 229, Centro, Guarulhos, SP, 07023-070, Brazil
| | - Maria Cristina C Espírito-Santo
- Laboratory of Immunopathology of Schistosomiasis (LIM-06), Department of Infectious and Parasitic Diseases, Faculty of Medicine, University of São Paulo, São Paulo, SP, Brazil.,Laboratory of Helminthology, Institute of Tropical Medicine, University of São Paulo, São Paulo, SP, Brazil
| | - Abolghasem Siyadatpanah
- Ferdows School of Paramedical and Health, Birjand University of Medical Sciences, 9717853577, Birjand, Iran
| | - Polrat Wilairatana
- Department of Clinical Tropical Medicine, Faculty of Tropical Medicine, Mahidol University, Bangkok, 10400, Thailand.
| | - Mara R C Couri
- Department of Chemistry, Federal University of Juiz de Fora, Juiz de Fora, MG, 36036-900, Brazil.
| | - Josué de Moraes
- Research Center for Neglected Diseases, Guarulhos University, Praça Tereza Cristina, 229, Centro, Guarulhos, SP, 07023-070, Brazil.
| |
Collapse
|
7
|
Silva BC, Mengarda AC, Rodrigues VC, Cajas RA, Carnaúba PU, Espírito-Santo MCC, Bezerra-Filho CSM, de Sousa DP, de Moraes J. Efficacy of carvacryl acetate in vitro and following oral administration to mice harboring either prepatent or patent Schistosoma mansoni infections. Parasitol Res 2021; 120:3837-3844. [PMID: 34604934 DOI: 10.1007/s00436-021-07333-2] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/03/2021] [Accepted: 09/24/2021] [Indexed: 10/20/2022]
Abstract
Schistosomiasis is a major public health problem that afflicts more than 240 million individuals globally, particularly in poor communities. Treatment of schistosomiasis relies heavily on a single oral drug, praziquantel, and there is interest in the search for new antischistosomal drugs. This study reports the anthelmintic evaluation of carvacryl acetate, a derivative of the terpene carvacrol, against Schistosoma mansoni ex vivo and in a schistosomiasis animal model harboring either adult (patent infection) or juvenile (prepatent infection) parasites. For comparison, data obtained with gold standard antischistosomal drug praziquantel are also presented. Initially in vitro effective concentrations of 50% (EC50) and 90% (EC90) were determined against larval and adult stages of S. mansoni. In an animal with patent infection, a single oral dose of carvacryl acetate (100, 200, or 400 mg/kg) caused a significant reduction in worm burden (30-40%). S. mansoni egg production, a process responsible for both life cycle and pathogenesis, was also markedly reduced (70-80%). Similar to praziquantel, carvacryl acetate 400 mg/kg had low efficacy in pre-patent infection. In tandem, although carvacryl acetate had interesting in vitro schistosomicidal activity, the compound exhibited low efficacy in terms of reduction of worm load in S. mansoni-infected mice.
Collapse
Affiliation(s)
- Bianca C Silva
- Núcleo de Pesquisa Em Doenças Negligenciadas, Universidade Guarulhos, R. Eng. Prestes Maia, 88, Centro, Guarulhos, SP, 07023-070, Brazil
| | - Ana C Mengarda
- Núcleo de Pesquisa Em Doenças Negligenciadas, Universidade Guarulhos, R. Eng. Prestes Maia, 88, Centro, Guarulhos, SP, 07023-070, Brazil
| | - Vinícius C Rodrigues
- Núcleo de Pesquisa Em Doenças Negligenciadas, Universidade Guarulhos, R. Eng. Prestes Maia, 88, Centro, Guarulhos, SP, 07023-070, Brazil
| | - Rayssa A Cajas
- Núcleo de Pesquisa Em Doenças Negligenciadas, Universidade Guarulhos, R. Eng. Prestes Maia, 88, Centro, Guarulhos, SP, 07023-070, Brazil
| | - Paulo U Carnaúba
- Núcleo de Pesquisa Em Doenças Negligenciadas, Universidade Guarulhos, R. Eng. Prestes Maia, 88, Centro, Guarulhos, SP, 07023-070, Brazil
| | - Maria Cristina C Espírito-Santo
- Laboratório de Imunopatologia da Esquistossomose (LIM-06), Departamento de Moléstias Infecciosas E Parasitárias, Faculdade de Medicina, Universidade de São Paulo, São Paulo, SP, Brazil
- Laboratório de Helmintologia, Instituto de Medicina Tropical de São Paulo, Universidade de São Paulo, SP, São Paulo, Brazil
| | - Carlos S M Bezerra-Filho
- Departamento de Ciências Farmacêuticas, Universidade Federal da Paraíba, João Pessoa, PB, Brazil
| | - Damião P de Sousa
- Departamento de Ciências Farmacêuticas, Universidade Federal da Paraíba, João Pessoa, PB, Brazil
| | - Josué de Moraes
- Núcleo de Pesquisa Em Doenças Negligenciadas, Universidade Guarulhos, R. Eng. Prestes Maia, 88, Centro, Guarulhos, SP, 07023-070, Brazil.
| |
Collapse
|
8
|
Carnaúba PU, Mengarda AC, Rodrigues VC, Morais TR, de Oliveira A, Lago JHG, de Moraes J. Evaluation of Gibbilimbol B, Isolated from Piper malacophyllum (Piperaceae), as an Antischistosomal Agent. Chem Biodivers 2021; 18:e2100503. [PMID: 34418297 DOI: 10.1002/cbdv.202100503] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/27/2021] [Accepted: 08/20/2021] [Indexed: 12/25/2022]
Abstract
Infections caused by parasitic worms impose a considerable worldwide health burden. One of the most impactful is schistosomiasis, a disease caused by blood-dwelling of the genus Schistosoma that affects more than 230 million people worldwide. Since praziquantel has also been extensively used to treat schistosomiasis and other parasitic flatworm infections, there is an urgent need to identify novel anthelmintic compounds, mainly from natural sources. In this study, the hexane extract from roots of Piper malacophyllum (Piperaceae) showed to be mainly composed for gibbilimbol B by HPLC/ESI-HRMS. Based on this result, this compound was isolated by chromatographic steps and its structure was confirmed by NMR. In vitro bioassays showed that gibbilimbol B was more active than praziquantel against larval stage of S. mansoni, with effective concentrations of 50 % (EC50 ) and 90 % (EC90 ) values of 2.6 and 3.4 μM, respectively. Importantly, gibbilimbol B showed no cytotoxicity to mammalian cells at a concentration 190 times greater than the antiparasitic effect, giving support for the anthelmintic potential of gibbilimbol B as lead compound for novel antischistosomal agents.
Collapse
Affiliation(s)
- Paulo U Carnaúba
- Núcleo de Pesquisa em Doenças Negligenciadas, Universidade Guarulhos, Praça Tereza Cristina, 88, Guarulhos, SP, 07023-070, Brazil
| | - Ana C Mengarda
- Núcleo de Pesquisa em Doenças Negligenciadas, Universidade Guarulhos, Praça Tereza Cristina, 88, Guarulhos, SP, 07023-070, Brazil
| | - Vinícius C Rodrigues
- Núcleo de Pesquisa em Doenças Negligenciadas, Universidade Guarulhos, Praça Tereza Cristina, 88, Guarulhos, SP, 07023-070, Brazil
| | - Thiago R Morais
- Núcleo de Pesquisa em Doenças Negligenciadas, Universidade Guarulhos, Praça Tereza Cristina, 88, Guarulhos, SP, 07023-070, Brazil
| | - Alberto de Oliveira
- Instituto de Química, Universidade Federal de Uberlândia, Av. João Naves de Ávila, 2121, Uberlândia, MG, 38408-100, Brazil
| | - João Henrique G Lago
- Centro de Ciências Naturais e Humanas, Universidade Federal do ABC, Avenida dos Estados, 5001, Santo André, SP, 09210-580, Brazil
| | - Josué de Moraes
- Núcleo de Pesquisa em Doenças Negligenciadas, Universidade Guarulhos, Praça Tereza Cristina, 88, Guarulhos, SP, 07023-070, Brazil
| |
Collapse
|
9
|
Porto R, Mengarda AC, Cajas RA, Salvadori MC, Teixeira FS, Arcanjo DDR, Siyadatpanah A, Pereira MDL, Wilairatana P, de Moraes J. Antiparasitic Properties of Cardiovascular Agents against Human Intravascular Parasite Schistosoma mansoni. Pharmaceuticals (Basel) 2021; 14:ph14070686. [PMID: 34358112 PMCID: PMC8308662 DOI: 10.3390/ph14070686] [Citation(s) in RCA: 11] [Impact Index Per Article: 3.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/18/2021] [Revised: 07/12/2021] [Accepted: 07/13/2021] [Indexed: 01/21/2023] Open
Abstract
The intravascular parasitic worm Schistosoma mansoni is a causative agent of schistosomiasis, a disease of great global public health significance. Praziquantel is the only drug available to treat schistosomiasis and there is an urgent demand for new anthelmintic agents. Adopting a phenotypic drug screening strategy, here, we evaluated the antiparasitic properties of 46 commercially available cardiovascular drugs against S. mansoni. From these screenings, we found that amiodarone, telmisartan, propafenone, methyldopa, and doxazosin affected the viability of schistosomes in vitro, with effective concentrations of 50% (EC50) and 90% (EC90) values ranging from 8 to 50 µM. These results were further supported by scanning electron microscopy analysis. Subsequently, the most effective drug (amiodarone) was further tested in a murine model of schistosomiasis for both early and chronic S. mansoni infections using a single oral dose of 400 mg/kg or 100 mg/kg daily for five consecutive days. Amiodarone had a low efficacy in chronic infection, with the worm and egg burden reduction ranging from 10 to 30%. In contrast, amiodarone caused a significant reduction in worm and egg burden in early infection (>50%). Comparatively, treatment with amiodarone is more effective in early infection than praziquantel, demonstrating the potential role of this cardiovascular drug as an antischistosomal agent.
Collapse
Affiliation(s)
- Raquel Porto
- Research Center for Neglected Diseases, Guarulhos University, Praça Tereza Cristina 229, São Paulo 07023-070, SP, Brazil; (R.P.); (A.C.M.); (R.A.C.)
| | - Ana C. Mengarda
- Research Center for Neglected Diseases, Guarulhos University, Praça Tereza Cristina 229, São Paulo 07023-070, SP, Brazil; (R.P.); (A.C.M.); (R.A.C.)
| | - Rayssa A. Cajas
- Research Center for Neglected Diseases, Guarulhos University, Praça Tereza Cristina 229, São Paulo 07023-070, SP, Brazil; (R.P.); (A.C.M.); (R.A.C.)
| | - Maria C. Salvadori
- Institute of Physics, University of São Paulo, São Paulo 05508-060, SP, Brazil; (M.C.S.); (F.S.T.)
| | - Fernanda S. Teixeira
- Institute of Physics, University of São Paulo, São Paulo 05508-060, SP, Brazil; (M.C.S.); (F.S.T.)
| | - Daniel D. R. Arcanjo
- Department of Biophysics and Physiology, Federal University of Piaui, Teresina 64049-550, PI, Brazil;
| | - Abolghasem Siyadatpanah
- Ferdows School of Paramedical and Health, Birjand University of Medical Sciences, Birjand 9717853577, Iran;
| | - Maria de Lourdes Pereira
- CICECO-Aveiro Institute of Materials & Department of Medical Sciences, University of Aveiro, 3810-193 Aveiro, Portugal;
| | - Polrat Wilairatana
- Department of Clinical Tropical Medicine, Faculty of Tropical Medicine, Mahidol University, Bangkok 10400, Thailand
- Correspondence: (P.W.); (J.d.M.)
| | - Josué de Moraes
- Research Center for Neglected Diseases, Guarulhos University, Praça Tereza Cristina 229, São Paulo 07023-070, SP, Brazil; (R.P.); (A.C.M.); (R.A.C.)
- Correspondence: (P.W.); (J.d.M.)
| |
Collapse
|
10
|
Mengarda AC, Silva MP, Cirino ME, Morais TR, Conserva GAA, Lago JHG, de Moraes J. Licarin A, a neolignan isolated from Nectandra oppositifolia Nees & Mart. (Lauraceae), exhibited moderate preclinical efficacy against Schistosoma mansoni infection. Phytother Res 2021; 35:5154-5162. [PMID: 34089558 DOI: 10.1002/ptr.7184] [Citation(s) in RCA: 7] [Impact Index Per Article: 2.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/12/2021] [Revised: 05/03/2021] [Accepted: 05/18/2021] [Indexed: 12/19/2022]
Abstract
Schistosomiasis is a widespread human parasitic disease currently affecting over 200 million people, particularly in poor communities. Chemotherapy for schistosomiasis relies exclusively on praziquantel (PZQ). Previous studies have shown that licarin A (LIC-A), a dihydrobenzofuran neolignan, exhibited in vitro antiparasitic activity against Schistosoma mansoni adult worms. This study aimed to investigate the potential of LIC-A, isolated as main metabolite from leaves of Nectandra oppositifolia Nees & Mart. (Lauraceae), as an antischistosomal agent orally active in schistosomiasis animal model. PZQ was used as a reference compound. As result, LIC-A showed, at a single dose of 400 mg/kg, to be able to partially cure infected mice (worm burden reductions of ~50%). Parasite eggs, that are responsible for a variety of pathologies and transmission of schistosomiasis, were also moderately inhibited by LIC-A (egg burden reductions of ~50%-60%). Furthermore, it was observed that LIC-A achieved a slight reduction of hepatomegaly and splenomegaly. Collectively, although LIC-A was partially active when administered orally, these results give support for the antiparasitic potential LIC-A as lead compound for novel antischistosomal agent.
Collapse
Affiliation(s)
- Ana C Mengarda
- Núcleo de Pesquisa em Doenças Negligenciadas, Universidade Guarulhos, Guarulhos, São Paulo, Brazil
| | - Marcos P Silva
- Núcleo de Pesquisa em Doenças Negligenciadas, Universidade Guarulhos, Guarulhos, São Paulo, Brazil
| | - Maria E Cirino
- Núcleo de Pesquisa em Doenças Negligenciadas, Universidade Guarulhos, Guarulhos, São Paulo, Brazil
| | - Thiago R Morais
- Núcleo de Pesquisa em Doenças Negligenciadas, Universidade Guarulhos, Guarulhos, São Paulo, Brazil
| | - Geanne A A Conserva
- Centro de Ciências Naturais e Humanas, Universidade Federal do ABC, Santo André, São Paulo, Brazil
| | - João Henrique G Lago
- Centro de Ciências Naturais e Humanas, Universidade Federal do ABC, Santo André, São Paulo, Brazil
| | - Josué de Moraes
- Núcleo de Pesquisa em Doenças Negligenciadas, Universidade Guarulhos, Guarulhos, São Paulo, Brazil
| |
Collapse
|
11
|
Silva MP, Silva TM, Mengarda AC, Salvadori MC, Teixeira FS, Alencar SM, Luz Filho GC, Bueno-Silva B, de Moraes J. Brazilian red propolis exhibits antiparasitic properties in vitro and reduces worm burden and egg production in an mouse model harboring either early or chronic Schistosoma mansoni infection. J Ethnopharmacol 2021; 264:113387. [PMID: 32918996 DOI: 10.1016/j.jep.2020.113387] [Citation(s) in RCA: 18] [Impact Index Per Article: 6.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Received: 07/25/2020] [Revised: 08/25/2020] [Accepted: 09/04/2020] [Indexed: 06/11/2023]
Abstract
ETHNOPHARMACOLOGICAL RELEVANCE Propolis has been used in folk medicine for thousands of years and, in the past few decades, it has attracted renewed interest. Although propolis has been traditionally used in many communities worldwide against parasitic diseases, its effect against Schistosoma mansoni infection remains unclear. AIM OF THE STUDY To demonstrate the effects of Brazilian red propolis on Schistosoma mansoni ex vivo and in an animal model of schistosomiasis. MATERIALS AND METHODS In vitro, we monitored phenotypic and tegumental changes as well as the effects of the crude extract of propolis on pairing and egg production. In a mouse infected with either immature (early infection) or adult (chronic infection) worms, propolis was administered by oral gavage and we studied the influence of this natural product on worm burden and egg production. RESULTS Propolis 25 μg/mL reduced motility and caused 100% mortality of adult parasites ex vivo. Further analysis revealed a pronounced reduction in oviposition after exposure to propolis at sub-lethal concentrations. In addition, scanning electron microscopy showed morphological alterations in the tegument of schistosomes. In the animal model, propolis markedly reduced worm burden and egg production in both early and chronic S. mansoni infection when compared to untreated control animals. CONCLUSIONS The efficacy of Brazilian red propolis in both in vitro and in vivo studies suggests its potential anthelmintic properties against S. mansoni infection.
Collapse
Affiliation(s)
- Marcos P Silva
- Núcleo de Pesquisa Em Doenças Negligenciadas, Universidade Guarulhos, Guarulhos, SP, Brazil.
| | - Thiago M Silva
- Núcleo de Pesquisa Em Doenças Negligenciadas, Universidade Guarulhos, Guarulhos, SP, Brazil.
| | - Ana C Mengarda
- Núcleo de Pesquisa Em Doenças Negligenciadas, Universidade Guarulhos, Guarulhos, SP, Brazil.
| | - Maria C Salvadori
- Instituto de Física, Universidade de São Paulo, São Paulo, SP, Brazil.
| | | | - Severino M Alencar
- Escola Superior de Agricultura "Luiz de Queiroz", Universidade de São Paulo, São Paulo, SP, Brazil.
| | | | - Bruno Bueno-Silva
- Departamento de Odontologia, Universidade Guarulhos, Guarulhos, SP, Brazil.
| | - Josué de Moraes
- Núcleo de Pesquisa Em Doenças Negligenciadas, Universidade Guarulhos, Guarulhos, SP, Brazil.
| |
Collapse
|
12
|
Sessa DP, Mengarda AC, Simplicio PE, Antar GM, Lago JHG, de Moraes J. 15β-Senecioyl-oxy- ent-kaur-16-en-19-oic Acid, a Diterpene Isolated from Baccharis lateralis, as Promising Oral Compound for the Treatment of Schistosomiasis. J Nat Prod 2020; 83:3744-3750. [PMID: 33236902 DOI: 10.1021/acs.jnatprod.0c01050] [Citation(s) in RCA: 16] [Impact Index Per Article: 4.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 06/11/2023]
Abstract
Praziquantel is the only available drug to treat schistosomiasis, and therefore, urgent studies must be performed to identify new anthelmintic agents. This study reports the anthelmintic evaluation of two related ent-kaurane diterpenes isolated from aerial parts of Baccharis lateralis (Asteraceae), ent-kaur-16-en-19-oic acid (1) and 15β-senecioyl-oxy-ent-kaur-16-en-19-oic acid (2) against Schistosoma mansoni in vitro and in a murine model of schistosomiasis. Both compounds exhibited in vitro activity with lethal concentration 50% (LC50) values of 26.1 μM (1) and 11.6 μM (2) as well as reduced toxicity against human cell lines, revealing a good selectivity profile, mainly with compound 2 (selectivity index > 10). Compound 2 also decreased egg production and caused morphological alterations in the parasite reproductive system. In mice infected with S. mansoni, oral treatment with compound 2 at 400 mg/kg, the standard dose used in this model of schistosomiasis, caused a significant reduction in a total worm burden of 61.9% (P < 0.01). S. mansoni egg production, a key mechanism for both transmission and pathogenesis, was also markedly reduced. In addition, compound 2 achieved a significant reduction in hepatosplenomegaly. Therefore, the diterpene 15β-senecioyl-oxy-ent-kaur-16-en-19-oic acid (2) has an acceptable cytotoxicity profile and is orally active in a murine schistosomiasis model.
Collapse
Affiliation(s)
- Deborah P Sessa
- Centro de Ciências Naturais e Humanas, Universidade Federal do ABC, Santo André, São Paulo 09210-180, Brazil
| | - Ana C Mengarda
- Núcleo de Pesquisa em Doenças Negligenciadas, Universidade Guarulhos, Guarulhos, São Paulo 07023-070, Brazil
| | - Paula E Simplicio
- Núcleo de Pesquisa em Doenças Negligenciadas, Universidade Guarulhos, Guarulhos, São Paulo 07023-070, Brazil
| | - Guilherme M Antar
- Departamento de Botânica, Instituto de Biociências, Universidade de São Paulo, São Paulo 05508-090, Brazil
| | - João Henrique G Lago
- Centro de Ciências Naturais e Humanas, Universidade Federal do ABC, Santo André, São Paulo 09210-180, Brazil
| | - Josué de Moraes
- Núcleo de Pesquisa em Doenças Negligenciadas, Universidade Guarulhos, Guarulhos, São Paulo 07023-070, Brazil
| |
Collapse
|
13
|
Xavier RP, Mengarda AC, Silva MP, Roquini DB, Salvadori MC, Teixeira FS, Pinto PL, Morais TR, Ferreira LLG, Andricopulo AD, de Moraes J. H1-antihistamines as antischistosomal drugs: in vitro and in vivo studies. Parasit Vectors 2020; 13:278. [PMID: 32487175 PMCID: PMC7268501 DOI: 10.1186/s13071-020-04140-z] [Citation(s) in RCA: 25] [Impact Index Per Article: 6.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/22/2020] [Accepted: 05/21/2020] [Indexed: 12/18/2022] Open
Abstract
Background Schistosomiasis is a socioeconomically devastating parasitic infection afflicting hundreds of millions of people and animals worldwide. It is the most important helminth infection, and its treatment relies solely on the drug praziquantel. Oral H1-antihistamines are available worldwide, and these agents are among the most widely used of all medications in children and adults. Given the importance of the drug repositioning strategy, we evaluated the antischistosomal properties of the H1-antihistamine drugs commonly used in clinical practices. Methods Twenty-one antihistamine drugs were initially screened against adult schistosomes ex vivo. Subsequently, we investigated the anthelmintic properties of these antihistamines in a murine model of schistosomiasis for both early and chronic S. mansoni infections at oral dosages of 400 mg/kg single dose or 100 mg/kg daily for five consecutive days. We also demonstrated and described the ability of three antihistamines to induce tegumental damage in schistosomes through the use of scanning electron microscopy. Results From phenotypic screening, we found that desloratadine, rupatadine, promethazine, and cinnarizine kill adult S. mansoni in vitro at low concentrations (5–15 µM). These results were further supported by scanning electron microscopy analysis. In an animal model, rupatadine and cinnarizine revealed moderate worm burden reductions in mice harboring either early or chronic S. mansoni infection. Egg production, a key mechanism for both transmission and pathogenesis, was also markedly inhibited by rupatadine and cinnarizine, and a significant reduction in hepatomegaly and splenomegaly was recorded. Although less effective, desloratadine also revealed significant activity against the adult and juvenile parasites. Conclusions Although the worm burden reductions achieved are all only moderate, comparatively, treatment with any of the three antihistamines is more effective in early infection than praziquantel. On the other hand, the clinical use of H1-antihistamines for the treatment of schistosomiasis is highly unlikely.![]()
Collapse
Affiliation(s)
- Rogério P Xavier
- Núcleo de Pesquisa em Doenças Negligenciadas, Universidade Guarulhos, Guarulhos, SP, Brazil
| | - Ana C Mengarda
- Núcleo de Pesquisa em Doenças Negligenciadas, Universidade Guarulhos, Guarulhos, SP, Brazil
| | - Marcos P Silva
- Núcleo de Pesquisa em Doenças Negligenciadas, Universidade Guarulhos, Guarulhos, SP, Brazil
| | - Daniel B Roquini
- Núcleo de Pesquisa em Doenças Negligenciadas, Universidade Guarulhos, Guarulhos, SP, Brazil
| | - Maria C Salvadori
- Instituto de Física, Universidade de São Paulo, São Paulo, SP, Brazil
| | | | - Pedro L Pinto
- Núcleo de Enteroparasitas, Instituto Adolfo Lutz, São Paulo, SP, Brazil
| | - Thiago R Morais
- Núcleo de Pesquisa em Doenças Negligenciadas, Universidade Guarulhos, Guarulhos, SP, Brazil
| | - Leonardo L G Ferreira
- Laboratório de Química Medicinal e Computacional, Instituto de Física de São Carlos, Universidade de São Paulo, São Paulo, SP, Brazil
| | - Adriano D Andricopulo
- Laboratório de Química Medicinal e Computacional, Instituto de Física de São Carlos, Universidade de São Paulo, São Paulo, SP, Brazil
| | - Josué de Moraes
- Núcleo de Pesquisa em Doenças Negligenciadas, Universidade Guarulhos, Guarulhos, SP, Brazil.
| |
Collapse
|
14
|
Mengarda AC, Mendonça PS, Morais CS, Cogo RM, Mazloum SF, Salvadori MC, Teixeira FS, Morais TR, Antar GM, Lago JHG, Moraes J. Antiparasitic activity of piplartine (piperlongumine) in a mouse model of schistosomiasis. Acta Trop 2020; 205:105350. [PMID: 31962096 DOI: 10.1016/j.actatropica.2020.105350] [Citation(s) in RCA: 20] [Impact Index Per Article: 5.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/06/2019] [Revised: 12/30/2019] [Accepted: 01/17/2020] [Indexed: 01/09/2023]
Abstract
Schistosomiasis is one of the most important parasitic infections in terms of its negative effects on public health and economics. Since praziquantel is currently the only drug available to treat schistosomiasis, there is an urgent need to identify new anthelmintic agents. Piplartine, also known as piperlongumine, is a biologically active alkaloid/amide from peppers that can be detected in high amounts in the roots of Piper tuberculatum. Previously, it has been shown to have in vitro schistosomicidal effects. However, its anthelmintic activity in an animal host has not been reported. In the present work, in vivo antischistosomal properties of isolated piplartine were evaluated in a mouse model of schistosomiasis infected with either adult (patent infection) or juvenile (pre-patent infection) stages of Schistosoma mansoni. A single dose of piplartine (100, 200 or 400 mg/kg) or daily doses for five consecutive days (100 mg/kg/day) administered orally to mice infected with schistosomes resulted in a reduction in worm burden and egg production. Treatment with the highest piplartine dose (400 mg/kg) caused a significant reduction in a total worm burden of 60.4% (P < 0.001) in mice harbouring adult parasites. S. mansoni egg production, a process responsible for pathology in schistosomiasis, was also significantly inhibited by piplartine. Studies using scanning electron microscopy revealed substantial tegumental alterations in parasites recovered from mice. Since piplartine has well-characterized mechanisms of toxicity, is easily available, and is cost-effective, our results indicate that this bioactive molecule derived from medicinal plants could be a potential lead compound for novel antischistosomal agents.
Collapse
Affiliation(s)
- Ana C Mengarda
- Núcleo de Pesquisa em Doenças Negligenciadas, Universidade Guarulhos, Praça Tereza Cristina, 229, Centro, 07023-070, Guarulhos, SP, Brazil
| | - Poliana S Mendonça
- Centro de Ciências Naturais e Humanas, Universidade Federal do ABC, Santo André, São Paulo, 09210-180, Brazil
| | - Cristiane S Morais
- Núcleo de Pesquisa em Doenças Negligenciadas, Universidade Guarulhos, Praça Tereza Cristina, 229, Centro, 07023-070, Guarulhos, SP, Brazil
| | - Ramon M Cogo
- Núcleo de Pesquisa em Doenças Negligenciadas, Universidade Guarulhos, Praça Tereza Cristina, 229, Centro, 07023-070, Guarulhos, SP, Brazil
| | - Susana F Mazloum
- Núcleo de Pesquisa em Doenças Negligenciadas, Universidade Guarulhos, Praça Tereza Cristina, 229, Centro, 07023-070, Guarulhos, SP, Brazil
| | - Maria C Salvadori
- Instituto de Física, Universidade de São Paulo, São Paulo, SP, Brazil
| | | | - Thiago R Morais
- Núcleo de Pesquisa em Doenças Negligenciadas, Universidade Guarulhos, Praça Tereza Cristina, 229, Centro, 07023-070, Guarulhos, SP, Brazil
| | - Guilherme M Antar
- Departamento de Botânica, Instituto de Biociências, Universidade de São Paulo, 05508-090, São Paulo, Brazil
| | - João Henrique G Lago
- Centro de Ciências Naturais e Humanas, Universidade Federal do ABC, Santo André, São Paulo, 09210-180, Brazil
| | - Josué Moraes
- Núcleo de Pesquisa em Doenças Negligenciadas, Universidade Guarulhos, Praça Tereza Cristina, 229, Centro, 07023-070, Guarulhos, SP, Brazil.
| |
Collapse
|
15
|
Mafud AC, Silva MP, Nunes GB, de Oliveira MA, Batista LF, Rubio TI, Mengarda AC, Lago EM, Xavier RP, Gutierrez SJ, Pinto PL, da Silva Filho AA, Mascarenhas YP, de Moraes J. Antiparasitic, structural, pharmacokinetic, and toxicological properties of riparin derivatives. Toxicol In Vitro 2018; 50:1-10. [DOI: 10.1016/j.tiv.2018.02.012] [Citation(s) in RCA: 29] [Impact Index Per Article: 4.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/10/2017] [Revised: 01/29/2018] [Accepted: 02/17/2018] [Indexed: 12/27/2022]
|
16
|
Silva MP, de Oliveira RN, Mengarda AC, Roquini DB, Allegretti SM, Salvadori MC, Teixeira FS, de Sousa DP, Pinto PL, da Silva Filho AA, de Moraes J. Antiparasitic activity of nerolidol in a mouse model of schistosomiasis. Int J Antimicrob Agents 2017; 50:467-472. [DOI: 10.1016/j.ijantimicag.2017.06.005] [Citation(s) in RCA: 41] [Impact Index Per Article: 5.9] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/29/2017] [Revised: 06/16/2017] [Accepted: 06/17/2017] [Indexed: 01/08/2023]
|